80 likes | 83 Views
global Drug Screening Market was worth USD 4.47 Billion in 2020, and it is further projected to reach a valuation of USD 14.14 Billion by 2027, at a CAGR of 18.6% during 2021-2027 (forecast period)
E N D
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 Global Drug Screening Market - Industry Trends & Forecast Report 2027 View report Sample report Press release Summary Global (Chromatography Instruments, Immunoassay Analyzers, and Breath Analyzers), Rapid Testing Devices (Oral Fluid Testing Devices and Urine Testing Devices), Consumables (Assay Kits), Laboratory Services, and Accessories (Calibrators & Controls, and Sample Collection Cups) ], By Sample Type [Oral Fluid/Saliva, Breath, Hair, Urine and Other Samples], By End User [Workplace & Schools, Criminal Justice, Hospitals, Drug Testing Laboratories, Personal Users, and Others], By Region [North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin America] Trend Analysis, Competitive Market Share & Forecast, 2017-2027 Drug Screening Market; By Product & Services [Equipment A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global drug screening market was worth USD 4.47 Billion in the year 2020 and anticipated to grow at a CAGR of 18.6% during 2021-2027 (forecast period). Concerns about growing alcohol and drug abuse cases around the world have contributed to the market's growth. The drug screening market has also grown in popularity due to increased demand from institutions such as workplaces, schools, and the sports industry. Drug testing is performed to screen athletes for drug misuse. It is also used for screening employers before hiring or random inspection. Rising public awareness
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 about the dangers of drug usage, as well as government funding for drug screening programs, have all contributed to the market's growth. The drug screening market has also grown as a result of new and diverse drug screening applications, as well as creative product developments. This has resulted in better services for customers, such as faster and more accurate results. However, the ongoing controversy over invasion of privacy as a result of drug screening has reduced market demand. The banning of alcohol consumption in many Islamic countries has also affected the geographical expansion of the drug and screening market across the globe. The drawback of the breathalyzer test's inefficiency has also resulted in a reduction in drug and screening market growth. The Global Drug Screening Market - Industry Trends & Forecast Report 2027 The global Drug Screening Market was worth USD 4.47 Billion in 2020, and it is further projected to reach a valuation of USD 14.14 Billion by 2027, at a CAGR of 18.6% during 2021-2027 (forecast period). The surge in market demand can be attributed to the increased necessity for the execution of rigorous regulations demanding drug and alcohol testing. The possibility of government support in this industry has also resulted in the worldwide drug screening market being promoted. However, the ban on alcohol consumption in some Islamic countries has reduced the demand for drug screening in many regions. The prohibition of drug testing at the workplace is also a restraining factor in further expansion of market growth. Drug Screening Market Overview Drug screening is a diagnostic test used to examine biological samples such as blood, hair, and urine to detect the presence of drug abuse or its metabolites in a person’s body. Drug screening tests are used to establish whether a suspected person is or was under the influence of effects of the drug at a certain period. It is used in organizations to monitor their employees and in the sports industry to detect drug abuse in athletes. The market's growth can be attributed to its widespread use in the workplace, criminal justice systems, law enforcement agencies, drug treatment clinics, the laboratory sector, and hospitals. For example, companies regulated by the United States Department of Transportation are subject to federal or state drug testing laws. However, the banning of drug testing in many organizations has resulted in a drop in the drug screening market's demand. Drug Screening Market Trends Growth Drivers Concern Over Increasing Alcohol and Drug Consumption Has Created A Demand for The Market. Global alcohol use and drug abuse have recently surged, which is cause for concern. Around 192 million people are consuming cannabis according to UN World Drug Report 2020. Over the last few years, the rate of opioid misuse mortality has risen by up to 71%. The cost of drug use is equivalent to losing 28 million years of healthy life. These startling figures are comparable to the rate of alcohol consumption. As a result, the number of accidents caused by drunk driving has
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 increased. These alarming numbers are similar to the alcohol consumption rate. This has resulted in a rising incidence of accidents due to drunk driving. According to National Crime Records Bureau, around 12,256 road accidents related to drunk driving occurred in 2019 in India alone. To curb this menace of alcohol and drug abuse, the demand for the drug screening market has increased. Also, governments and agencies of many countries are working towards initiatives to expand this market and regulate their concern. Market Opportunities Are Rising Due to The Adoption Of Innovative Methods. The launch of new products and development in drug screening has created immense opportunities for the growth of the global drug screening market. Apart from alcohol and drug testing, it is being applied in clinical and research studies as well. For example, carvedilol was identified as a possible therapy for retinitis pigmentosa through drug screening utilizing zebrafish visual behavior. The incorporation of new technology into various analytical instruments such as spectroscopic devices and inhalers has improved the drug screening market's services. An increase in government financing for drug testing, as well as increased public awareness of its use, has increased market demand around the world. For example, the United States has strict drug-abuse regulations and requires alcohol and drug testing through the Drug-Free Workplace Act. Restraints Prohibition of A Drug Screening In Several Organizations Many countries such as Canada, Colombia, Argentina, Chile, and South Africa consider alcohol and drug testing in the workplace as a violation of employees' privacy. These organizational policies have hindered the growth of the drug screening market by affecting demand. For instance, drug and alcohol testing in the workplace is strictly prohibited in Poland and the Czech Republic. This lack of demand from the largest end-user market, i.e., the workplace, has hampered the growth of the global drug screening market. The prohibition on alcohol consumption in several Islamic nations has also had an impact on market demand. Concerns about the accuracy of breathalyzers have also contributed to the drug screening market's lackluster appeal. Impact of COVID-19 The coronavirus outbreak has led to the downfall of many markets across the globe. Many industrial, manufacturing, production, and business development institutions were forced to shut down for an extended period of time due to nationwide lockdowns. The nationwide shutdown has had an impact on the availability of products and services to the drug screening business. As a result, the market's growth has slowed significantly. The market's progress was hampered by disruptions in the global supply chain and a supply-demand mismatch. Furthermore, with the healthcare sector's major focus on COVID- related cases, the number of drug and alcohol testing cases has plummeted, affecting demand from various end-use industries.
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 Drug Screening Market- By Products & Services Based on products & services, the Drug Screening Market has been categorized into equipment, rapid testing devices, consumables, laboratory services, accessories, and others. For instance, coronavirus fast antigen testing kits became very popular during the pandemic. The rapid testing devices have been further segmented into oral fluid testing devices and urine testing devices. The urine testing devices segment held the largest share in the market in 2020. Also, the oral fluid testing devices segment is expected to contribute the highest market share during the forecast period. Urine testing devices are becoming more popular as a result of the useful services they provide, such as shorter detection times, quick results, non-invasive nature, and low risk of sample tampering. Drug Screening Market- By End-Users Based on end-users, the drug screening market has been categorized into workplace & schools, laboratories, criminal justice, hospital, drug testing laboratories, personal users, and others. In 2020, the workplace segment registered the largest market share. Pre-employment, reasonable suspicion, post- accident, return-to-duty, and monthly drug testing are some of the scenarios in which an organization conducts drug testing. The rise in the workplace segment is also due to increased concern over workplace security and performance. Thus, many organizations have made drug screening a mandatory process. For instance, as many as 90% of Fortune 200 companies currently use some kind of drug testing for their employees. However, issues have arisen in the past over how this practice is a violation of employees' privacy. Drug Screening Market- Regional Insights Based on region, the drug screening market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the global market with the largest share in 2020. Increased demand for drug screening has resulted from the alarming prevalence of illicit drug consumption in this region. Furthermore, the drug screening business in this region has grown as a result of government support and favorable policies aimed at reducing drug usage. For instance, The Army Substance Abuse Program is an anti-substance abuse program of the U.S. overseen by the Army Centre for Substance Abuse Program. However, the Asia-Pacific region is expected to exhibit the highest growth in the global drug screening market during the forecast period. China and India have emerged as the highest growing economy for this market. The rising number of drug addicts, coupled with increased awareness of the importance of drug screening, and the development of improved technology for this industry are driving the market growth. According to a National Survey conducted by United Nations Office on Drugs and Crime, it was reported that 732 lakh people in India are users of alcohol and drugs. Competitive Landscape The Drug Screening Market is highly competitive and fragmented with international and regional players. The key players dominating the market are LabCorp, Quest Diagnostics, Abbott Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk Rapid Diagnostics, OraSure
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 AG, Lifeloc Inc., Psychemedics Healthcare, BioMerieux Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. Routine screening initiatives and marketing activities, and programs carried out by some key players, such as Quest Technologies developing a Drug Testing Index, have improved their productivity. These strategies, along with new product launches, collaboration with government & organizations, and awareness campaigns, are adopted by companies to stay competitive in the market. Technologies, MPD Corporation, Roche AG, Shimadzu Corporation, Siemens SA, Synergy Health Inc., Omega Laboratories, Premier Biotech plc., CareHealth America Recent Developments · In June 2021, Amazon.com Inc announced that it supports the federal legalization of marijuana and has decided to drop marijuana-testing requirements for some sections of its workers. · In May 2021, Quidel Corporation began selling its non-prescription QuickVue At-Home OTC COVID-19 Test online through Amazon in the United States. Scope Attribute Details Years Considered Historical data – 2017-2020 Base Year – 2020 Forecast – 2021 – 2027 Facts Covered Revenue in USD XXX Million Market Coverage The U.S., Canada, Germany, the U.K., France, Italy, Netherlands, Russia, Brazil, Mexico, Argentina, Colombia, Japan, South Korea, China, India, Australia, New Zealand, UAE, South Africa, Saudi Arabia, Turkey, Kuwait, Qatar, Nigeria, Kenya, Iran By-Products & Services, By Sample Type, By End-User, and By Region Key players in include are LabCorp, Quest Diagnostics, Abbott Diagnostics, OraSure Technologies, Alfa Designs, Thermo Scientific, Dragerwerk Technologies, MPD Laboratories, Premier Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux Health plc., CareHealth Spain, Belgium, Product/Service Segmentation Key Players the market Rapid Scientific Fisher AG, Lifeloc Inc., Omega Biotech SA, Synergy America
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 Corporation, Biomedical Diagnostics, Agilent Technologies, and other players. prominent By Product & Service · Equipment o Immunoassay Analysers o Chromatography Instruments o Breath Analyzers o Other Devices · Rapid Testing Devices o Urine Testing Devices o Oral Fluid Testing Devices · Consumables o Assay Kits · Laboratory Services · Accessories o Sample Collection Cups o Calibrators and Controls By Sample Type · Oral Fluid or Saliva Sample · Breath Sample · Hair Sample · Urine Sample · Others By End-User · Workplace and Schools · Criminal Justice System · Hospitals · Drug Testing Laboratories · Personal Users · Others By Region North America Europe The Asia-Pacific Latin America The Middle-East & Africa
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027 About us Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade- off. Delivering quality insights into several product or service markets within the timeline as per the needs of the clients has earned BWC an excellent reputation among clients. BWC strives to provide timely and accurate digital market intelligence services for making your business endeavours successful. For more information, kindly visit our Website www.blueweaveconsulting.com contact us at info@blueweaveconsulting.com
Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027